Kineret® (anakinra)
for Arthritis Rheumatoid

Kineret (anakinra) is an FDA-approved IL-1 receptor antagonist that reduces inflammation by blocking IL-1. It treats moderate to severe rheumatoid arthritis, neonatal-onset multisystem inflammatory disease (NOMID) in newborns, and deficiency of interleukin-1 receptor antagonist (DIRA) in adults and children. It also has emergency use authorization for certain hospitalized COVID-19 patients at risk of severe respiratory failure.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Arthritis Rheumatoid